3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1/2
1
Status
Unknown
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Cardiotoxicity
2
Breast Neoplasms
2
Heart Failure
1
Interventions
Trastuzumab
2
Ivabradine
2
Exercise
2
Echocardiography
2
Bisoprolol
2
salicylhydroxamic acid
1
sacubitril and valsartan sodium hydrate drug combination
1
mitoquinone
1
epicatechin gallate
1
dapagliflozin
1
candesartan
1
Trimetazidine
1
Therapeutics
1
Surveys and Questionnaires
1
Spironolactone
1
Silymarin
1
Secondary Prevention
1
Restraint, Physical
1
Ramipril
1
Radiotherapy
1
Perindopril
1
Neoadjuvant Therapy
1
Nebivolol
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
Fluorouracil
1
Epirubicin
1
Docetaxel
1
Cyclophosphamide
1
Cisplatin
1
Carvedilol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Cardiotoxicity
×
Bisoprolol
×
Clear all
NCT02236806
2022-02-01
SAFE
Azienda Ospedaliero-Universitaria Careggi
Phase 3
Unknown
262 enrolled
NCT01016886
2016-02-09
MANTICORE
AHS Cancer Control Alberta
Phase 1/2
Unknown
99 enrolled